Prevention of posterior capsule opacification by intraoperative single-dose pharmacologic agents

Simple item page
dc.contributor.authorInan Ü.Ü.
dc.contributor.authorÖztürk F.
dc.contributor.authorKaynak S.
dc.contributor.authorKurt E.
dc.contributor.authorEmiroǧlu L.
dc.contributor.authorÖzer E.
dc.contributor.authorIlker S.S.
dc.contributor.authorGüler C.
dc.date.accessioned2024-07-22T08:25:30Z
dc.date.available2024-07-22T08:25:30Z
dc.date.issued2001
dc.description.abstractPurpose: To determine whether an intraoperative single dose of dexamethasone, diclofenac, ethylenediaminetetraacetic acid (EDTA), a combination of EDTA and RGD peptide (arginine-glycin-aspartic acid sequence), or mitomycin-C (MMC) is a pharmacological means of preventing or reducing the development of posterior capsule opacification (PCO). Setting: Department of Ophthalmology, Celal Bayar University, School of Medicine, Manisa, and Department of Pathology, Dokur Eylül University, School of Medicine, izmir, Turkey. Methods: Fifty-four rabbits were randomly divided into 6 groups. Dexamethasone (4 mg/cc), diclofenac (2.5 mg/cc), EDTA (8 mg/cc), a combination of EDTA and RGD peptide (2.5 mg/cc), or MMC (0.04 mg/cc) was given, 0.1 cc by hydrodissection and 0.9 cc into the capsular bag after phacoemulsification. The sixth group served as a control group. After 3 months, the PCO was graded clinically and the proliferation of lens epithelial cells (LECs) was evaluated histologically. Results: The drugs were significantly effective in preventing PCO compared with the control (P < .005). Dexamethasone had a weaker effect than the other drugs. In histological analysis, although monolayer LECs in the dexamethasone and diclofenac groups were observed, there was no proliferative activity on the posterior capsules in the EDTA, EDTA+RGD, and MMC groups in contrast to the multilayer cells in the control. Conclusions: Intraoperative single-dose application of EDTA, EDTA+ RGD peptide combination, and MMC significantly prevented the development of PCO in rabbit eyes. Diclofenac was less effective but also reduced PCO. Although dexamethasone did not prevent the proliferation of LECs, it decreased PCO clinically. © 2001 ASCRS and ESCRS.
dc.identifier.DOI-ID10.1016/S0886-3350(00)00886-5
dc.identifier.issn08863350
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/20462
dc.language.isoEnglish
dc.publisherElsevier Inc.
dc.subjectarginylglycylaspartic acid
dc.subjectdexamethasone
dc.subjectdiclofenac
dc.subjectedetic acid
dc.subjectmitomycin C
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectanimal tissue
dc.subjectarticle
dc.subjectcataract
dc.subjectcell proliferation
dc.subjectcontrolled study
dc.subjectdrug efficacy
dc.subjecthistology
dc.subjectlens epithelium
dc.subjectnonhuman
dc.subjectphacoemulsification
dc.subjectpriority journal
dc.subjectrabbit
dc.subjectTurkey (republic)
dc.titlePrevention of posterior capsule opacification by intraoperative single-dose pharmacologic agents
dc.typeArticle

Files

Collections

Scopus Koleksiyonu